1. C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. (May 2022) Authors: Klümper, Niklas; Sikic, Danijel; Saal, Jonas; Büttner, Thomas; Goldschmidt, Franziska; Jarczyk, Jonas; Becker, Philippe; Zeuschner, Philip; Weinke, Maximilian; Kalogirou, Charis; Breyer, Johannes; Burger, Maximilian; Nuhn, Philipp; Tully, Karl; Roghmann, Florian; Bolenz, Christian; Zengerling, Fr... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy. Issue 1 (24th May 2020) Authors: Eckstein, Markus; Strissel, Pamela; Strick, Reiner; Weyerer, Veronika; Wirtz, Ralph; Pfannstiel, Carolin; Wullweber, Adrian; Lange, Fabienne; Erben, Philipp; Stoehr, Robert; Bertz, Simone; Geppert, Carol Imanuel; Fuhrich, Nicole; Taubert, Helge; Wach, Sven; Breyer, Johannes; Otto, Wolfgang; Burge... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma. Issue 12 (6th December 2021) Authors: Klümper, Niklas; Schmucker, Philipp; Hahn, Oliver; Höh, Benedikt; Mattigk, Angelika; Banek, Severine; Ellinger, Jörg; Heinzelbecker, Julia; Sikic, Danijel; Eckstein, Markus; Strauß, Arne; Zengerling, Friedemann; Hölzel, Michael; Zeuschner, Philip; Kalogirou, Charis Journal: Clinical & translational immunology Issue: Volume 10:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non‐muscle‐invasive bladder cancer. (9th September 2018) Authors: Breyer, Johannes; Wirtz, Ralph M.; Erben, Philipp; Rinaldetti, Sebastien; Worst, Thomas S.; Stoehr, Robert; Eckstein, Markus; Sikic, Danijel; Denzinger, Stefan; Burger, Maximilian; Hartmann, Arndt; Otto, Wolfgang Journal: BJU international Issue: Volume 123:Number 1(2019) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort. Issue 2 (28th September 2021) Authors: Kullmann, Friederike; Strissel, Pamela L; Strick, Reiner; Stoehr, Robert; Eckstein, Markus; Bertz, Simone; Wullich, Bernd; Sikic, Danijel; Wach, Sven; Taubert, Helge; Olbert, Peter; Heers, Hendrik; Lara, María Fernanda; Macias, Maria Luisa; Matas-Rico, Elisa; Lozano, Maria José; Prieto, Daniel; H... Journal: Journal of clinical pathology Issue: Volume 76:Issue 2(2023) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis. Issue 11 (13th November 2015) Authors: Kunath, Frank; Borgmann, Hendrik; Blümle, Anette; Keck, Bastian; Wullich, Bernd; Schmucker, Christine; Sikic, Danijel; Roelle, Catharina; Schmidt, Stefanie; Wahba, Amr; Meerpohl, Joerg J Journal: BMJ open Issue: Volume 5:Issue 11(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. (January 2019) Authors: Eckstein, Markus; Erben, Philipp; Kriegmair, Maximilian C.; Worst, Thomas S.; Weiß, Cleo-Aron; Wirtz, Ralph M.; Wach, Sven; Stoehr, Robert; Sikic, Danijel; Geppert, Carol I.; Weyerer, Veronika; Bertz, Simone; Breyer, Johannes; Otto, Wolfgang; Keck, Bastian; Burger, Maximilian; Taubert, Helge; Wei... Journal: European journal of cancer Issue: Volume 106(2019) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients. Issue 1 (December 2018) Authors: Eckstein, Markus; Jung, Rudolf; Weigelt, Katrin; Sikic, Danijel; Stöhr, Robert; Geppert, Carol; Agaimy, Abbas; Lieb, Verena; Hartmann, Arndt; Wullich, Bernd; Wach, Sven; Taubert, Helge Journal: Scientific reports Issue: Volume 8:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗